ISPE Drug Shortages Team
Chairman: François Sallans, Vice President and Chief Quality Officer, Johnson & Johnson
- Thomas Hartman, Vice President, GlaxoSmithKline (Steering Committee Chair)
- Peter Bigelow, President, XCell Strategic Consulting, LLC
- John Bournas, President and CEO, ISPE
- Joseph C. Famulare, Vice President, Genentech Inc.
- Frances Zipp, President, Lachman Consulting Services, Inc.
- François Sallans Chairman, Vice President and Chief Quality Officer, Johnson & Johnson (Core Team Chair)
- Andreas Brutsche, Head of Global Quality Assurance, Sandoz International GmbH
- Paul D’Eramo, Vice President, Johnson & Johnson
- Mairead Goetz, Head of Compliance, Novartis Pharmaceutical Corporation
- Donna Gulbinski, Senior Vice President, Bristol-Meyers Squibb Co.
- Karen Hirshfield, Senior Compliance Specialist, Genentech, Inc. (Member of the Roche Group)
- Paige Kane, Director Knowledge Management, Pfizer Global Supply
- Larry Kranking, Vice President, Commissioning Agents, Inc.
- Stephen Mahoney, Senior Director, Genentech, Inc. (Member of the Roche Group)
- Robert Landertinger-Forero, Marketing Manager, Sartorius Stedim Biotech GmbH
- David Mierau, Director of Reliability Solutions, Life Cycle Engineering
- Christopher Reid, CEO, Integrity Solutions
- Shannah Schodle, Director of Business Development, CRB
- David Sponseller, Supply Chain Leader, Pfizer Global Supply
- Sumanth Venugopal, Director, PricewaterhouseCoopers LLP
- Carol Winfield, Director of Regulatory Operations, ISPE (Staff Project Manager)
- John C. Berridge, PhD, ISPE Advisor
- Anna Maria Di Giorgio, Senior Director, Publications, ISPE
- Alicia Montes, Director of Training, ISPE
- Bryan Wright, ISPE Regulatory Advisor
- Thomas Zimmer, Vice President of European Operations, ISPE